These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23266401)

  • 1. Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.
    Iankov ID; Penheiter AR; Griesmann GE; Carlson SK; Federspiel MJ; Galanis E
    Virus Res; 2013 Mar; 172(1-2):15-23. PubMed ID: 23266401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical characterization and single-chain Fv construction of a neutralizing antibody to measles virus.
    Tadokoro T; Jahan ML; Ito Y; Tahara M; Chen S; Imai A; Sugimura N; Yoshida K; Saito M; Ose T; Hashiguchi T; Takeda M; Fukuhara H; Maenaka K
    FEBS J; 2020 Jan; 287(1):145-159. PubMed ID: 31287622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.
    de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME
    J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
    Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
    J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization.
    Zhou D; Zhang Y; Li Q; Chen Y; He B; Yang J; Tu H; Lei L; Yan H
    J Virol; 2011 Nov; 85(21):11090-7. PubMed ID: 21865386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.
    Muñoz-Alía MÁ; Muller CP; Russell SJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein.
    Zhang X; Wallace OL; Domi A; Wright KJ; Driscoll J; Anzala O; Sanders EJ; Kamali A; Karita E; Allen S; Fast P; Gilmour J; Price MA; Parks CL
    Virology; 2015 Aug; 482():218-24. PubMed ID: 25880113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.
    Vogt MR; Dowd KA; Engle M; Tesh RB; Johnson S; Pierson TC; Diamond MS
    J Virol; 2011 Nov; 85(22):11567-80. PubMed ID: 21917960
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.
    Moi ML; Lim CK; Chua KB; Takasaki T; Kurane I
    PLoS Negl Trop Dis; 2012; 6(2):e1536. PubMed ID: 22389741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
    Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
    J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.
    Tahara M; Ito Y; Brindley MA; Ma X; He J; Xu S; Fukuhara H; Sakai K; Komase K; Rota PA; Plemper RK; Maenaka K; Takeda M
    J Virol; 2013 Jan; 87(1):666-75. PubMed ID: 23115278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Requirement of Fc-Fcγ Receptor Interactions for
    Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
    Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
    PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.
    Haralambieva IH; Ovsyannikova IG; O'Byrne M; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Jun; 29(27):4485-91. PubMed ID: 21539880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.